JP2022500387A5 - - Google Patents
Info
- Publication number
- JP2022500387A5 JP2022500387A5 JP2021513331A JP2021513331A JP2022500387A5 JP 2022500387 A5 JP2022500387 A5 JP 2022500387A5 JP 2021513331 A JP2021513331 A JP 2021513331A JP 2021513331 A JP2021513331 A JP 2021513331A JP 2022500387 A5 JP2022500387 A5 JP 2022500387A5
- Authority
- JP
- Japan
- Prior art keywords
- containing seq
- chain variable
- variable domain
- cdr1
- cdr2
- Prior art date
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024191894A JP2025016653A (ja) | 2018-09-10 | 2024-10-31 | Ｍｕｓｋ阻害 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL2021589A NL2021589B1 (en) | 2018-09-10 | 2018-09-10 | MuSK inhibition |
| NL2021589 | 2018-09-10 | ||
| NL2023119 | 2019-05-13 | ||
| NL2023119 | 2019-05-13 | ||
| PCT/NL2019/050576 WO2020055240A1 (en) | 2018-09-10 | 2019-09-05 | Musk inhibition |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024191894A Division JP2025016653A (ja) | 2018-09-10 | 2024-10-31 | Ｍｕｓｋ阻害 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022500387A JP2022500387A (ja) | 2022-01-04 |
| JPWO2020055240A5 JPWO2020055240A5 (https=) | 2022-09-14 |
| JP2022500387A5 true JP2022500387A5 (https=) | 2022-09-14 |
Family
ID=68138766
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021513331A Pending JP2022500387A (ja) | 2018-09-10 | 2019-09-05 | Ｍｕｓｋ阻害 |
| JP2024191894A Pending JP2025016653A (ja) | 2018-09-10 | 2024-10-31 | Ｍｕｓｋ阻害 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024191894A Pending JP2025016653A (ja) | 2018-09-10 | 2024-10-31 | Ｍｕｓｋ阻害 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220002438A1 (https=) |
| EP (1) | EP3850014A1 (https=) |
| JP (2) | JP2022500387A (https=) |
| CN (1) | CN113614112A (https=) |
| AU (1) | AU2019337338A1 (https=) |
| CA (1) | CA3112288A1 (https=) |
| IL (1) | IL281409A (https=) |
| WO (1) | WO2020055240A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114487448B (zh) * | 2022-01-21 | 2022-10-18 | 天津天海新域生物科技有限公司 | 用于检测重症肌无力相关抗体的组合物、试剂盒及应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5204244A (en) | 1987-10-27 | 1993-04-20 | Oncogen | Production of chimeric antibodies by homologous recombination |
| US5202238A (en) | 1987-10-27 | 1993-04-13 | Oncogen | Production of chimeric antibodies by homologous recombination |
| US5814478A (en) | 1995-12-15 | 1998-09-29 | Regeneron Pharmaceuticals, Inc. | Tyrosine kinase receptors and ligands |
| EP1411851B1 (en) | 2001-08-03 | 2006-11-02 | Tyco Healthcare Group LP | Marker for use with a tissue marking apparatus |
| US7759314B2 (en) * | 2001-08-15 | 2010-07-20 | Brown University | Treatment of muscular dystrophies and related disorders |
| US6921538B2 (en) | 2002-05-10 | 2005-07-26 | Allergan, Inc. | Therapeutic treatments for neuropsychiatric disorders |
| US7807378B2 (en) * | 2005-12-29 | 2010-10-05 | Industrial Technology Research Institute (Itri) | Method of diagnosing myasthenia gravis and kits therefor |
| CN101490085A (zh) * | 2006-06-12 | 2009-07-22 | 特鲁比昂药品公司 | 具有效应功能的单链多价结合蛋白 |
| JP2011207769A (ja) * | 2010-03-29 | 2011-10-20 | Arubion:Kk | 化粧料及び皮膚外用剤 |
| JP2014520148A (ja) * | 2011-06-20 | 2014-08-21 | セントルイス ユニバーシティ | 治療のための神経筋接合部への標的化 |
| WO2013074636A1 (en) * | 2011-11-14 | 2013-05-23 | New York University | Muscle specific receptor kinase and modulation thereof |
| WO2015039015A2 (en) * | 2013-09-13 | 2015-03-19 | New York University | Methods for treating muscle specific receptor kinase myasthenia gravis |
| JP7023840B2 (ja) * | 2015-10-07 | 2022-02-22 | メモリアル スローン ケタリング キャンサー センター | 神経筋接合活性のモジュレーターを同定するｉｎ ｖｉｔｒｏの方法 |
-
2019
- 2019-09-05 US US17/272,791 patent/US20220002438A1/en not_active Abandoned
- 2019-09-05 AU AU2019337338A patent/AU2019337338A1/en not_active Abandoned
- 2019-09-05 EP EP19783152.2A patent/EP3850014A1/en active Pending
- 2019-09-05 WO PCT/NL2019/050576 patent/WO2020055240A1/en not_active Ceased
- 2019-09-05 CN CN201980074121.1A patent/CN113614112A/zh active Pending
- 2019-09-05 CA CA3112288A patent/CA3112288A1/en active Pending
- 2019-09-05 JP JP2021513331A patent/JP2022500387A/ja active Pending
-
2021
- 2021-03-10 IL IL281409A patent/IL281409A/en unknown
-
2024
- 2024-10-31 JP JP2024191894A patent/JP2025016653A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020062036A5 (https=) | ||
| JP2021191763A5 (https=) | ||
| IL295230A (en) | Combination therapy with anti-cd73 antibodies | |
| JP2021098733A5 (https=) | ||
| JP2009541492A5 (https=) | ||
| IL273424B2 (en) | Novel bispecific cd3/cd19 polypeptide complexes | |
| JP2019513701A5 (https=) | ||
| JP2015500207A5 (https=) | ||
| JP2021523140A5 (https=) | ||
| JP2020533311A5 (ja) | ＮＫＧ２Ｄ、ＣＤ１６およびＮｅｃｔｉｎ４に結合するタンパク質 | |
| HRP20230344T1 (hr) | Protutijela protiv sortilina i postupci njihove upotrebe | |
| RU2019140602A (ru) | АНТИ-GARP-TGF-β-АНТИТЕЛА | |
| JP2009530423A5 (https=) | ||
| JP2019536470A5 (https=) | ||
| JP2019509055A5 (https=) | ||
| WO2006121852A3 (en) | Anti-cd19 antibody therapy for autoimmune disease | |
| PE20091474A1 (es) | Anticuerpos monoclonales contra la proteina rgm a y sus usos | |
| JP2018535948A5 (https=) | ||
| HRP20120701T1 (hr) | Humana monoklonska protutijela protiv fukozil-gm1 i postupci za uporabu antifukozil-gm1 | |
| JPWO2019224718A5 (https=) | ||
| RU2015144105A (ru) | Антитела к гепсидину и их применения | |
| JP2019527194A5 (https=) | ||
| RU2009136913A (ru) | Биспецифические связывающие агенты с межвидовой специфичностью | |
| JP2024016024A5 (https=) | ||
| JP2017534646A5 (https=) |